Special Issues

Special Issues
Mechanism of Pathway: Considerations of Cytogenetic and Molecular Mutation Status for Patients with Acute Myeloid Leukemia: and Ongoing Testing Across the Care Continuum
View this Issue
2018 Third Annual Oncology Guide to New FDA Approvals
View this Issue
Front-Line Treatment of Patients with Advanced Hodgkin Lymphoma
View this Issue
June 2017, Vol 8, No 3, Supplement 2: The Evolution of Chemotherapy-Induced Nausea and Vomiting Management: Challenges and Opportunities
View this Issue
Highlights from Best Practices in Lung Cancer Navigation Summit
View this Issue
February 2017, Vol 8, No 1, Supplement 1: Balancing Innovation and Value in Cancer Care: Spotlight on Non–Small-Cell Lung Cancer Treatment
View this Issue
Consolidation Therapy After ASCT in Hodgkin Lymphoma: Why and Who to Treat
View this Issue
August 2016, Vol 7, No7, Special Issue: Payers’ Perspectives in Oncology
View this Issue
Mechanism of Action Magnifier – 2016 Desk Reference
View this Issue
Dx Profiler: Can Metastatic Cancer with Diagnostic Ambiguity Be Treated Based on Mutational Status Alone?
View this Issue
Mechanism of Pathway: Phosphatidylserine, an Immune-Modulating Checkpoint, Ushers in the Next Wave of Immuno-Oncology Targets
View this Issue
Mechanism of Action: Key Advances in Hematology Oncology
View this Issue
Mechanism of Action: Novel Mechanisms in Lung Cancer
View this Issue
Mechanism of Action: Novel Mechanisms in CINV Treatment
View this Issue
Mechanism of Pathway: The Promise of PD-1 Pathway Blockade in the Treatment of Metastatic Cancer
View this Issue